| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Increased risk of cancer |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Radium-228 | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Increased risk of cancer |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Cardiovascular system or reproductive problems |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Cardiovascular system or reproductive problems |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Oct 1, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Oct 1, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Oct 1, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |